Jazz, United HealthCare reach settlements ahead of trial in US Xyrem case
Jazz Pharmaceuticals and a class suing the company for allegedly scheming to delay entry of a generic version of narcolepsy drug Xyrem have “reached a settlement in principle,” class counsel told...To view the full article, register now.
Already a subscriber? Click here to view full article